Torbjörn Larsson
Corporate Officer/Principal chez GUARD THERAPEUTICS INTERNATIONAL AB
Provenance du réseau au premier degré de Torbjörn Larsson
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Torbjörn Larsson via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
University of Gothenburg | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
University of Uppsala | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
SCANDI STANDARD AB (PUBL) | Food: Meat/Fish/Dairy | Chairman Director/Board Member | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Karolinska Institutet | College/University | Corporate Officer/Principal Graduate Degree | |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
DEVYSER DIAGNOSTICS AB | Medical Specialties | Director/Board Member Director/Board Member | |
COREM PROPERTY GROUP AB | Real Estate Development | Chairman Director/Board Member | |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Private Equity Investor | |
OT Pharmaceuticals AB | Chief Executive Officer | ||
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member | |
Synartro AB | Chairman | ||
OT Lehmann Holding AB
OT Lehmann Holding AB Investment Banks/BrokersFinance OT Lehmann Holding AB provides securities and property management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Recipharm OT Chemistry AB
Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ELECTROLUX AB | Electronics/Appliances | Corporate Officer/Principal | |
University of Adelaide | College/University | Investor Relations Contact | |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Kabigen AB | Investor Relations Contact | ||
Actinova AB | Director/Board Member | ||
Active Biotech Research AB
Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Active Biotech Research AB develops pharmaceuticals. The private company is based in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Active Security Trading AB | Director/Board Member | ||
CANTARGIA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
ACTIVE BIOTECH AB | Biotechnology | Investor Relations Contact | |
Actionaid AB | Chairman | ||
Gideon & Partners AB | Director/Board Member | ||
OnTarget Chemistry AB
OnTarget Chemistry AB BiotechnologyHealth Technology Part of Recipharm AB, OnTarget Chemistry AB provides research services for medicinal synthesis and pharmaceutical products. The company is based in Uppsala, Sweden. OnTarget Chemistry was acquired by Recipharm AB on June 15, 2015 for $1.85 million. | Biotechnology | Chief Executive Officer | |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member | |
University of Stockholm | College/University | Graduate Degree | |
LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
Antaros Holding AB | Director/Board Member | ||
Antaros Renostic AB | Chairman | ||
Antaros Medical AB
Antaros Medical AB Miscellaneous Commercial ServicesCommercial Services Antaros Medical AB provides scientific, technical, research and development services. The private company is based in Stockholm, Sweden. The Swedish company was founded by Johannes Hulthe. Johannes Hulthe has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard Medical School | College/University | Doctorate Degree | |
Sybo invest AB
Sybo invest AB Miscellaneous Commercial ServicesCommercial Services Sybo Invest AB is a private company based in Oskarshamn, Sweden. The Swedish company specializes in various areas such as saddlery, sewing car interiors, cat breeding, and car fittings. The company is known for their expertise in these fields, particularly in their Sybo Sadelmakeri, Sybo Kattuppfödning, Sybo Bilinredningar, and Sybo Maine Coon divisions. | Miscellaneous Commercial Services | Director/Board Member | |
Matting Holding AB | Director/Board Member | ||
Matting AB
Matting AB Home FurnishingsConsumer Durables Matting AB supplies carpets for shops, offices, public environments, and industry. It offers entrance mats, workplace mats, and tactile joints and rugs for dog sports arenas. The firm also provides lightning. The company was founded in 1970 and is headquartered in Alingsas, Sweden. | Home Furnishings | Director/Board Member | |
Novartis Healthcare A/S
Novartis Healthcare A/S Pharmaceuticals: MajorHealth Technology Novartis Healthcare A/S sells medical and healthcare products. It offers a wide range of medical treatment for Attention Deficit Hyperactivity Disorder, allergic asthma, blood cancer, heart failure, Chronic Obstructive Pulmonary Disease, multiple Sclerosis, psoriasis, and other rare diseases. The company was founded on December 17, 1997 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Core Ventures LLC
Core Ventures LLC Investment ManagersFinance Core Ventures LLC is an Independent Venture Capital firm founded in 2009. Core Ventures LLC is headquartered in Short Hills. | Investment Managers | Chief Investment Officer | |
Gårdarike Fastigheter AB | Director/Board Member | ||
SIMRIS GROUP AB | Biotechnology | Chairman | |
AB Consiliario | Director/Board Member | ||
Gårdarike Invest AB | Director/Board Member | ||
Gårdarike AB
Gårdarike AB Real Estate DevelopmentFinance Gårdarike AB manages real estate properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
Naventus Corporate Finance AB
Naventus Corporate Finance AB Investment Banks/BrokersFinance Naventus Corporate Finance AB is an independent investment boutique and transaction manager headquartered in Stockholm, Sweden. The firm was founded by Lars Höckenström in 2017. Naventus Corporate Finance aims to, together with their clients, secure successful capital markets transactions and to achieve optimal results. They build a long-term strategy and strengthen value creation for clients. | Investment Banks/Brokers | Founder |
Statistiques
Internationale
Suède | 44 |
Etats-Unis | 4 |
Islande | 2 |
Australie | 2 |
Royaume-Uni | 2 |
Sectorielle
Health Technology | 18 |
Consumer Services | 8 |
Finance | 7 |
Commercial Services | 5 |
Consumer Durables | 3 |
Opérationnelle
Director/Board Member | 74 |
Independent Dir/Board Member | 20 |
Chairman | 16 |
Corporate Officer/Principal | 14 |
Chief Executive Officer | 7 |
Relations les plus connectées
- Bourse
- Insiders
- Torbjörn Larsson
- Connexions Sociétés